Production (Stage)
MIRA Pharmaceuticals, Inc.
MIRA
$1.40
$0.032.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 35.93% | 34.46% | -48.99% | -121.67% | -78.49% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -200.00% | -200.00% | -- |
| Total Other Non-Cash Items | -72.80% | -76.26% | 189.79% | 598.25% | 481.09% |
| Change in Net Operating Assets | 11.92% | 158.03% | 127.52% | -75.87% | -170.48% |
| Cash from Operations | -36.27% | -22.68% | -7.10% | -16.97% | 2.82% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | 78.26% |
| Total Debt Repaid | 102.08% | 100.00% | -459.20% | -451.28% | -1,810.85% |
| Issuance of Common Stock | -60.11% | -60.15% | -66.49% | 664.08% | 585.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 51.37% | 145.82% | -83.64% | -160.00% | -66.14% |
| Cash from Financing | -52.47% | -56.84% | -69.80% | 132.80% | 219.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -165.84% | -141.62% | -130.34% | 449.38% | 266.27% |